Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Expert Opinion on Biological Therapy|August 13, 2002
Oestrogen has neuroprotective effects and may reduce the risk of Alzheimer's diseaseJamie L EberlingAlcohol Health and Research World|December 5, 2019
Imaging Studies of Aging, Neurodegenerative Disease, and AlcoholismJamie L Eberling, William J JagustJournal of Parkinson'S Disease|November 7, 2013
α-synuclein imaging: a critical need for Parkinson's disease researchJamie L Eberling, Kuldip D Dave, Mark A FrasierNeuroimage|August 25, 2004
Comparison of two methods for the analysis of [18F]6-fluoro-L-m-tyrosine PET dataJamie L Eberling, Phillip Pivirotto, John Bringas, et al.Neuroimage|January 27, 2004
Estrogen- and tamoxifen-associated effects on brain structure and functionJamie L Eberling, Christine Wu, Regina Tong-Turnbeaugh, et al.Neurobiology of Aging|March 12, 2004
Enhanced cutaneous vascular response in AD subjects under donepezil therapyJonathan S Maltz, Jamie L Eberling, William J Jagust, et al.Frontiers in Human Neuroscience|October 30, 2008
PET 6-[F]fluoro-L-m-tyrosine Studies of Dopaminergic Function in Human and Nonhuman PrimatesJamie L Eberling, Krystof S Bankiewicz, James P O'Neil, et al.Annals of the New York Academy of Sciences|December 14, 2002
Imaging Interactions between Alzheimer's disease and cerebrovascular diseaseChristine C Wu, Dan Mungas, Jamie L Eberling, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 10, 2010
Eight years of clinical improvement in MPTP-lesioned primates after gene therapy with AAV2-hAADCPiotr Hadaczek, Jamie L Eberling, Philip Pivirotto, et al.Frontiers in Bioscience : a Journal and Virtual Library|September 6, 2003
Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changesYoshitsugu Oiwa, Jamie L Eberling, Dea Nagy, et al.Pageof 3